JPWO2023010098A5 - - Google Patents

Info

Publication number
JPWO2023010098A5
JPWO2023010098A5 JP2024504950A JP2024504950A JPWO2023010098A5 JP WO2023010098 A5 JPWO2023010098 A5 JP WO2023010098A5 JP 2024504950 A JP2024504950 A JP 2024504950A JP 2024504950 A JP2024504950 A JP 2024504950A JP WO2023010098 A5 JPWO2023010098 A5 JP WO2023010098A5
Authority
JP
Japan
Prior art keywords
seq
sequence
variable region
chain variable
domain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024504950A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024527043A (ja
JP2024527043A5 (https=
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/074284 external-priority patent/WO2023010098A2/en
Publication of JP2024527043A publication Critical patent/JP2024527043A/ja
Publication of JP2024527043A5 publication Critical patent/JP2024527043A5/ja
Publication of JPWO2023010098A5 publication Critical patent/JPWO2023010098A5/ja
Pending legal-status Critical Current

Links

JP2024504950A 2021-07-28 2022-07-28 新規多重特異性分子 Pending JP2024527043A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
CNPCT/CN2021/109028 2021-07-28
CN2021109028 2021-07-28
CNPCT/CN2022/103725 2022-07-04
CN2022103725 2022-07-04
PCT/US2022/074284 WO2023010098A2 (en) 2021-07-28 2022-07-28 Novel multi-specific molecules

Publications (3)

Publication Number Publication Date
JP2024527043A JP2024527043A (ja) 2024-07-19
JP2024527043A5 JP2024527043A5 (https=) 2025-08-04
JPWO2023010098A5 true JPWO2023010098A5 (https=) 2025-08-04

Family

ID=85088266

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024504950A Pending JP2024527043A (ja) 2021-07-28 2022-07-28 新規多重特異性分子

Country Status (10)

Country Link
US (1) US20240336686A1 (https=)
EP (1) EP4377357A2 (https=)
JP (1) JP2024527043A (https=)
KR (1) KR20240039005A (https=)
CN (1) CN118055946A (https=)
AU (1) AU2022319934A1 (https=)
CA (1) CA3226306A1 (https=)
MX (1) MX2024001328A (https=)
TW (1) TW202311296A (https=)
WO (1) WO2023010098A2 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4217396A4 (en) * 2020-09-28 2025-06-18 Elpiscience (Suzhou) Biopharma, Ltd. NEW ANTI-CLAUDIN18 ANTIBODIES
CN120569409A (zh) * 2023-01-18 2025-08-29 科望(苏州)生物医药科技有限公司 靶向sirpa和claudin 18.2的双特异性分子

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111032085A (zh) * 2017-06-05 2020-04-17 昆士兰医学研究所理事会 用于癌症治疗或预防的免疫检查点分子拮抗剂和rank-l（nf-kb配体）拮抗剂的组合或其双特异性结合分子及其用途

Similar Documents

Publication Publication Date Title
JP6779299B2 (ja) 抗ｐｄ−ｌ１抗体およびその使用
JP2020501531A5 (https=)
US11155625B2 (en) Anti-PD-1 antibodies and uses thereof
US11352429B2 (en) Anti-PD-1 antibodies and uses thereof
US20240002539A1 (en) Multispecific antibodies and uses thereof
WO2020089794A1 (en) Methods of treating cancer
JP2023037000A (ja) 抗ｃｄ４０抗体及びその使用
WO2024088346A1 (en) Anti-ccr8 antibodies and uses thereof
WO2025036476A1 (en) Anti-b7-h3 antibodies and uses thereof
JPWO2023010098A5 (https=)
JPWO2020205331A5 (https=)
JPWO2023010100A5 (https=)
WO2024255467A1 (en) Anti-ccr8 antibody and anti-ccr8/ctla4 bispecific antibody
US20250129174A1 (en) Anti-4-1-1bbxccr8 antibodies and uses thereof
WO2025180385A1 (en) Anti-egfr/cd70 antibodies and uses thereof
WO2024175020A1 (en) Anti-il2ra antibodies and uses thereof
US20250270318A1 (en) Multispecific antibodies and uses thereof
TW202535936A (zh) 靶向liv-1之抗體及其用途
WO2025072322A1 (en) Anti-4-1bb and anti-ccr8 antibodies and uses thereof
RU2022107092A (ru) Новые анти-cldn18.2 антитела
TW202446799A (zh) 抗體及其用途
TW202602939A (zh) 一種多特異性抗體t細胞銜接器
AU2024294026A1 (en) Multispecific antibodies and uses thereof
TW202535953A (zh) 靶向密連蛋白６之抗體及抗體－藥物結合物
CN118272524A (zh) Cd74的医药用途